Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

  1. Martin, M.
  2. Villar, A.
  3. Sole-Calvo, A.
  4. Gonzalez, R.
  5. Massuti, B.
  6. Lizon, J.
  7. Camps, C.
  8. Carrato, A.
  9. Casado, A.
  10. Candel, M.T.
  11. Albanell, J.
  12. Aranda, J.
  13. Munarriz, B.
  14. Campbell, J.
  15. Diaz-Rubio, E.
Zeitschrift:
Annals of Oncology

ISSN: 0923-7534

Datum der Publikation: 2003

Ausgabe: 14

Nummer: 6

Seiten: 833-842

Art: Artikel

DOI: 10.1093/ANNONC/MDG260 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus